Biogen Inc at Stifel CNS Days (Virtual) Transcript
Great. Thank you very much, everybody. It's my pleasure to be hosting Priya Singhal, Biogen's Interim Head of Research and Development, this morning. We'll have a lot to talk about as it relates to Alzheimer's, neuropsychiatry, antisense oligonucleotides and anything else Priya thinks that I'm overlooking here that definitely needs more attention.
Questions & Answers
But maybe we can start with conversation around Alzheimer's, Priya. And I assume there's not a ton you can say, but I'd be remiss at not at least asking for an update on where things stand ahead of the final NCD and if you think there's any sort of plausible path to materially modifying things as we get the final decision?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
